Source disclosure: February 09, 2026
Eisai Co., Ltd. [4523.T]
TOKYO, Feb 09 (Pulse News Wire) – Eisai CO.,LTD. (4523.T) announced today that its board of directors has decided on a new executive structure effective April 1, 2026.
- Yasuyuki Saeki stays on as Senior Managing Director, Americas Region President, and Chairman & CEO of Eisai Inc. - Lin Kramer continues as Chief Clinical Officer. - Sachie Sasaki remains as China Business Officer, Japan & Asia Registration Manager. - Akira Kanazawa continues as East Asia Global South Region President and API Production General Manager. - Akiko Nakahama retains her role as Production, Quality, Technology, and Pharmaceutical Affairs Officer. - Kazumi Masuzoe remains as Chief HR Officer and Corporate Administration Officer.
- Kohei Osaka continues as Corporate General Affairs Officer. - Noboru Uejima stays on as EMEA Region President, Chairman & CEO of Eisai Europe Limited, Strategy Officer, and Global Value & Portfolio Officer. - Shun Aso continues as Development Officer. - Makoto Hoketsu remains as Chief Information Officer. - Jin Kato continues as General Counsel, Chief Compliance Officer, Intellectual Property, and Internal Control Officer. - Hisayuki Yuasa retains his position as Japan Business Officer. - Kentaroh Ido continues as Chief Scientific Officer. - Takuya Oyama remains as Chief Financial Officer and IR Officer. Additionally, Gary Handler, who was previously serving as EMEA Region President and Chairman & CEO of Eisai Europe Limited, will retire from his positions.
AI-translated content. 🟢 Confidence: High See terms • Original filing